🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Study Objectives 1. Evaluate the efficacy of the combination of thalidomid...
Status
Completed
Location
Weill Medical College of Cornell University
Start Date
2007-10
Trial ID
NCT00538733
Treatments Being Tested
The purpose of this study is to compare a standard chemotherapy regimen of ...
Status
Unknown
Location
112 sites UK wide
Start Date
2010-05
Trial ID
NCT01554852
Treatments Being Tested
This protocol is an international, multicenter, comparative, open and rando...
Status
Unknown
Location
Hospital Universitário Clementino Fraga Filho
Start Date
2007-01
Trial ID
NCT01532856
The primary purpose of this study is to determine the overall response rate...
Status
Withdrawn
Location
CEHON Centro de Hematologia e Oncologia da Bahia
Start Date
2019-09-30
Trial ID
NCT03608501
Treatments Being Tested
Multiple Myeloma is a incurable disease. Thalidomide in combination with ot...
Status
Unknown
Location
Je-Jung Lee
Start Date
2006-06
Trial ID
NCT00349115
Treatments Being Tested
RATIONALE: Bortezomib and thalidomide may stop the growth of multiple myelo...
Status
Completed
Location
City of Hope Medical Center
Start Date
2008-01-16
Trial ID
NCT00792142
Multicentric study, open, single arm, designed to evaluate the efficacy(res...
Status
Completed
Location
Hospital Morales Messeguer
Start Date
2007-01
Trial ID
NCT00652041
Treatments Being Tested
The purpose of this study is to determine if bortezomib when added to conso...
Status
Completed
Location
Multiple Locations
Start Date
2012-01-13
Trial ID
NCT01539083
Treatments Being Tested
This study is a phase 2, single-arm, open-label, multi-institutional trial ...
Status
Unknown
Location
Seoul National University Bundang Hospital
Start Date
2016-11-21
Trial ID
NCT03335098
Treatments Being Tested
RATIONALE: Bortezomib may stop the growth of cancer cells by blocking some ...
Status
Unknown
Location
Alta Bates Summit Comprehensive Cancer Center
Start Date
2006-08
Trial ID
NCT00438841
Treatments Being Tested